Try our mobile app

Published: 2021-02-11 08:00:18 ET
<<<  go to COHU company page
EX-99.1 2 ex_225609.htm EXHIBIT 99.1 ex_225609.htm

Exhibit 99.1

 

   
logo.jpg
 

COHU, INC.

12367 CROSTHWAITE CIRCLE

POWAY, CA 92064

FAX (858) 848-8185

PHONE (858) 858-8100

www.cohu.com

 

Cohu Reports Fourth Quarter and Full Year 2020 Operating Results

 

 

Fifth consecutive year of revenue growth; 5-year CAGR 18.7%

 

Record fourth quarter revenue $202.4 million; up 34% quarter-over-quarter

 

Fourth quarter gross margin of 45.1%; non-GAAP gross margin of 45.0%

 

Record fourth quarter orders driven by mobility, automotive and industrial segment strength

 

POWAY, Calif., February 11, 2020 -- Cohu, Inc. (NASDAQ: COHU), a global leader in back-end semiconductor equipment and services, today reported fiscal 2020 fourth quarter net sales of $202.4 million and a GAAP income of $14.9 million or $0.34 per share. Net sales for full year 2020 were $636.0 million and GAAP loss was $13.8 million or $0.33 per share.(1)

 

The Company also reported non-GAAP results, with fourth quarter 2020 income of $31.8 million or $0.73 per share and income of $50.7 million or $1.19 per share for full year 2020.(1)

 

GAAP Results (1)

                                       

(in millions, except per share amounts)

 

Q4 FY 2020

   

Q3 FY 2020

   

Q4 FY 2019

   

12 Months 2020

   

12 Months 2019

 
                                         

Net sales

  $ 202.4     $ 150.6     $ 142.0     $ 636.0     $ 583.3  

Income (loss)

  $ 14.9     $ (6.6 )   $ (16.3 )   $ (13.8 )   $ (69.0 )

Income (loss) per share

  $ 0.34     $ (0.16 )   $ (0.39 )   $ (0.33 )   $ (1.68 )

 

Non-GAAP Results (1)

                                       

(in millions, except per share amounts)

 

Q4 FY 2020

   

Q3 FY 2020

   

Q4 FY 2019

   

12 Months 2020

   

12 Months 2019

 
                                         

Income (loss)

  $ 31.8     $ 11.6     $ (0.5 )   $ 50.7     $ 3.8  

Income (loss) per share

  $ 0.73     $ 0.27     $ (0.01 )   $ 1.19     $ 0.09  

 

 

(1)

All amounts presented are from continuing operations.

 

Total cash and investments at year-end 2020 were $170.0 million. During the fourth quarter, the Company further reduced its Term Loan B debt associated with the financing of the Xcerra acquisition by $20.9 million.

 

“Cohu ended 2020 on a high note with record fourth quarter orders and strong momentum for our semiconductor testers and handlers. Our interface business secured a key design-win for mmWave test at a leading foundry in Taiwan and OSAT in Korea,” said Cohu President and CEO Luis Müller. “We made substantial improvements to our product portfolio over the past two years and have positioned the company for continued growth over the mid-term. Cohu is successfully enabling testing of new high-growth technologies in RF, battery management and ADAS processors, and gaining traction in automated optical inspection.”

 

Cohu expects first quarter 2021 sales to be between $212 million and $232 million.

 

Conference Call Information:

 

The Company will host a live conference call and webcast with slides to discuss fourth quarter 2020 results at 5:30 a.m. Pacific Time/8:30 a.m. Eastern Time on February 11, 2020. Interested investors and analysts are invited to dial into the conference call by using 1-866-434-5330 (domestic) or +1-213-660-0873 (international) and entering the pass code 5445848. Webcast access will be available on the Investor Information section of the Company’s website at www.cohu.com.

 

 

 

About Cohu:

 

Cohu (NASDAQ: COHU) is a global leader in back-end semiconductor equipment and services, delivering leading-edge solutions for the manufacturing of semiconductors and printed circuit boards. Additional information can be found at www.cohu.com.

 

Use of Non-GAAP Financial Information:

 

Included within this press release and accompanying materials are non-GAAP financial measures, including non-GAAP Gross Margin/Profit, Income and Income (adjusted earnings) per share, Operating Income, Operating Expense and Adjusted EBITDA that supplement the Company’s Condensed Consolidated Statements of Operations prepared under generally accepted accounting principles (GAAP). These non-GAAP financial measures adjust the Company’s actual results prepared under GAAP to exclude charges and the related income tax effect for: share-based compensation, employer payroll taxes related to accelerated vesting share-based awards, the amortization of purchased intangible assets, restructuring costs, manufacturing transition and severance costs, asset impairment charges, acquisition-related costs and associated professional fees, reduction of indemnification receivable, gain on sale of facilities, depreciation of purchase accounting adjustments to property, plant and equipment, purchase accounting inventory step-up included in cost of sales and amortization of cloud-based software implementation costs (Adjusted EBITDA only). Reconciliations of GAAP to non-GAAP amounts for the periods presented herein are provided in schedules accompanying this release and should be considered together with the Condensed Consolidated Statements of Operations. With respect to any forward looking non-GAAP figures, we are unable to provide without unreasonable efforts, at this time, a GAAP to non-GAAP reconciliation of any forward-looking figures due to their inherent uncertainty.

 

These non-GAAP measures are not meant as a substitute for GAAP, but are included solely for informational and comparative purposes. The Company’s management believes that this information can assist investors in evaluating the Company’s operational trends, financial performance, and cash generating capacity. Management uses non-GAAP measures for a variety of reasons, including to make operational decisions, to determine executive compensation in part, to forecast future operational results, and for comparison to our annual operating plan. However, the non-GAAP financial measures should not be regarded as a replacement for (or superior to) corresponding, similarly captioned, GAAP measures.

 

Forward Looking Statements:

 

Certain statements contained in this release and accompanying materials may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding strong momentum for our semiconductor testers and handlers, having positioned the company for continued growth over the mid-term, successfully enabling testing of new technologies in RF, battery management and ADAS processors and gaining traction in automated optical inspection, key design-wins, ADAS, 5G and mobility market segments growth, any comments on Cohu’s FY 2021 outlook or growth, target financial model for FY’21, % of incremental revenue expected to fall to operating income, debt deleveraging priority, Cohu’s first and second quarter 2021 sales forecast, guidance, sales mix, non-GAAP operating expenses, gross margin, adjusted EBITDA, effective tax rate, free cash flow, cap ex, and cash and shares outstanding, estimated minimum cash needed, estimated EBITDA breakeven point, any future Term Loan B principal reduction, and any other statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Any third party industry analyst forecasts quoted are for reference only and Cohu does not adopt or affirm any such forecasts.

 

 

 

Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the ongoing global COVID-19 pandemic has adversely affected, and is continuing to adversely affect, our business and results of operations; we are making investments in new products and product enhancements, which may adversely affect our operating results and these investments may not be commercially successful; we are exposed to the risks of operating a global business; we have manufacturing operations in Asia, and any failure to effectively manage multiple manufacturing sites and to secure raw materials meeting our quality, cost and other requirements, or failures by our suppliers to perform, could harm our sales, service levels and reputation; failure of critical suppliers to deliver sufficient quantities of parts in a timely and cost-effective manner could adversely impact us our operations; the semiconductor industry is seasonal, volatile and unpredictable; the semiconductor equipment and printed circuit board (“PCB”) test industries are intensely competitive; semiconductor equipment is subject to rapid technological change, product introductions and transitions which may result in inventory write-offs, and our new product development involves numerous risks and uncertainties; the seasonal nature of the semiconductor equipment industry places enormous demands on our employees, operations and infrastructure; a limited number of customers account for a substantial percentage of our net sales; a majority of our revenues are generated from exports to foreign countries, primarily in Asia, that are subject to economic and political instability and we compete against a number of Asia-based test contactor, test handler, automated test equipment and PCB test suppliers; the incurrence of substantial indebtedness in connection with our financing of the Xcerra acquisition may have an adversely impact on Cohu’s liquidity, limit Cohu’s flexibility in responding to other business opportunities and increase Cohu’s vulnerability to adverse economic and industry conditions; our Credit Agreement contains various representations and negative covenants that limit, subject to certain exceptions and baskets, our ability and/or our subsidiaries’ ability to enter into financing and other transactions relating to our assets; because of high debt levels we may not be able to service our debt obligations in accordance with their terms; we are exposed to other risks associated with other acquisitions, investments and divestitures; we expect to continue to evaluate and pursue divestitures of non-core assets; our financial and operating results may vary and fall below analysts’ estimates, or credit rating agencies may change their ratings on Cohu, any of which may cause the price of our common stock to decline or make it difficult to obtain other financing; potential goodwill impairments if our business underperforms; global economic and political conditions, including trade tariffs and export restrictions, and other regulatory requirements, have impacted our business and may continue to have an adverse impact on our business and financial condition; and our business and operations could suffer in the event of cybersecurity breaches.

 

These and other risks and uncertainties are discussed more fully in Cohu’s filings with the SEC, including the most recently filed Form 10-K and Form 10-Q, and the other filings made by Cohu with the SEC from time to time, which are available via the SEC’s website at www.sec.gov. Except as required by applicable law, Cohu does not undertake any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

 

For press releases and other information of interest to investors, please visit Cohu’s website at www.cohu.com.

 

Contact:

Cohu, Inc.
Jeffrey D. Jones - Investor Relations
858-848-8106

 

 

COHU, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except per share amounts)

   

Three Months Ended (1)

   

Twelve Months Ended (1)

 
   

December 26,

   

December 28,

   

December 26,

   

December 28,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Net sales

  $ 202,355     $ 142,011     $ 636,007     $ 583,329  

Cost and expenses:

                               

Cost of sales (excluding amortization)

    111,114       87,936       364,225       353,500  

Research and development

    22,762       20,823       86,151       86,147  

Selling, general and administrative (2)

    33,584       34,532       129,248       142,936  

Amortization of purchased intangible assets

    9,898       9,615       38,746       39,590  

Restructuring charges

    6,223       2,764       7,623       13,484  

Impairment charges (3)

    -       -       11,249       -  

Gain on sale of facilities (4)

    -       -       (4,495 )     -  
      183,581       155,670       632,747       635,657  

Income (loss) from operations

    18,774       (13,659 )     3,260       (52,328 )

Other (expense) income:

                               

Interest expense

    (2,855 )     (4,767 )     (13,759 )     (20,556 )

Gain (loss) on extinguishment of debt (5)

    (25 )     -       268       -  

Interest income

    14       161       224       764  

Foreign transaction gain (loss)

    (642 )     (1,259 )     (3,170 )     43  

Income (loss) from continuing operations before taxes

    15,266       (19,524 )     (13,177 )     (72,077 )

Income tax provision (benefit)

    405       (3,243 )     666       (3,082 )

Income (loss) from continuing operations

    14,861       (16,281 )     (13,843 )     (68,995 )
                                 

Discontinued operations: (6)

                               

Income (loss) from discontinued operations before taxes

    -       (1,061 )     46       (661 )

Income tax provision (benefit)

    -       (22 )     4       36  

Income (loss) from discontinued operations

    -       (1,039 )     42       (697 )

Net income (loss)

    14,861       (17,320 )   $ (13,801 )   $ (69,692 )

Net income (loss) attributable to noncontrolling interest

    -       (54 )     -       8  

Net income (loss) attributable to Cohu

  $ 14,861     $ (17,266 )   $ (13,801 )   $ (69,700 )
                                 

Income (loss) per share:

                               

Basic:

                               

Income (loss) from continuing operations before noncontrolling interest

  $ 0.35     $ (0.39 )   $ (0.33 )   $ (1.68 )

Income (loss) from discontinued operations

    -       (0.03 )     0.00       (0.01 )

Net income (loss) attributable to noncontrolling interest

    -       0.00       -       0.00  

Net income (loss) attributable to Cohu

  $ 0.35     $ (0.42 )   $ (0.33 )   $ (1.69 )
                                 

Diluted:

                               

Income (loss) from continuing operations before noncontrolling interest

  $ 0.34     $ (0.39 )   $ (0.33 )   $ (1.68 )

Income (loss) from discontinued operations

    -       (0.03 )     0.00       (0.01 )

Net income (loss) attributable to noncontrolling interest

    -       0.00       -       0.00  

Net income (loss) attributable to Cohu

  $ 0.34     $ (0.42 )   $ (0.33 )   $ (1.69 )
                                 

Weighted average shares used in computing income (loss) per share: (7)

                               

Basic

    42,125       41,409       41,854       41,159  

Diluted

    43,486       41,409       41,854       41,159  

 

(1)

The three- and twelve-month periods ended December 26, 2020 and December 28, 2019 were both comprised of 13 weeks and 52 weeks, respectively.

 

(2)

For the three- and twelve-month period ended December 28, 2019 Xcerra transaction costs were $28,000 and $0.4 million. No transaction costs were incurred during 2020.

 

(3)

Included in our results for the twelve-month period ended December 26, 2020 are impairment charges recorded to write certain of our in-process research and development assets (“IPR&D”) obtained as part of our acquisition of Xcerra down to current estimated fair values.

 

(4)

During 2020 we completed the sale of our facilities in Rosenheim, Germany and in Penang, Malaysia which generated a gain of $4.5 million. Both facilities were sold as part of the previously announced Xcerra integration program.

 

(5)

In the fourth quarter of 2020 we repurchased and retired $20.0 million of our outstanding Term Loan B which resulted in a loss from the extinguishment of debt. For the full year ended December 26, 2020, total repurchases and retirements of Term Loan B were $36.4 million and resulted in a gain from the extinguishment of debt. Gain or loss on extinguishment of debt is the net result after any cash gain is offset by the required reduction in our capitalized debt issuance costs and original issuance discounts.

 

(6)

On October 1, 2018, the Company made the decision to sell the fixtures business acquired from Xcerra, and, as a result, the operating results of this business have been presented as discontinued operations. In February 2020, we completed the sale of this business. In the fourth quarter of 2019, we recognized a loss on disposal of $1.1 million primarily related to the write-off of goodwill and purchased intangible assets.

 

(7)

For the twelve-month periods ended December 26, 2020 and for the three- and twelve-month periods ended December 28, 2019, potentially dilutive securities were excluded from the per share computations due to their antidilutive effect. The Company has utilized the "control number" concept in the computation of diluted earnings per share to determine whether a potential common stock instrument is dilutive. The control number used is income from continuing operations. The control number concept requires that the same number of potentially dilutive securities applied in computing diluted earnings per share from continuing operations be applied to all other categories of income or loss, regardless of their anti-dilutive effect on such categories.

 

COHU, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)

 

   

December 26,

   

December 28,

 
   

2020

   

2019

 

Assets:

               

Current assets:

               

Cash and investments

  $ 170,027     $ 156,098  

Accounts receivable

    151,919       127,921  

Inventories

    142,500       130,706  

Other current assets

    21,071       21,468  

Current assets of discontinued operations (1)

    -       3,503  

Total current assets

    485,517       439,696  

Property, plant & equipment, net

    66,916       70,912  

Goodwill

    252,304       238,669  

Intangible assets, net

    233,685       275,019  

Operating lease right of use assets

    29,203       33,269  

Other assets

    27,886       20,030  

Noncurrent assets of discontinued operations (1)

    -       115  

Total assets

  $ 1,095,511     $ 1,077,710  
                 

Liabilities & Stockholders’ Equity:

               

Current liabilities:

               

Short-term borrowings

  $ 5,314     $ 3,195  

Current installments of long-term debt

    3,075       3,322  

Deferred profit

    8,671       7,645  

Other current liabilities

    157,864       134,124  

Current liabilities of discontinued operations (1)

    -       599  

Total current liabilities

    174,924       148,885  

Long-term debt

    311,551       346,518  

Non-current operating lease liabilities

    25,787       28,877  

Other noncurrent liabilities

    71,625       70,334  

Noncurrent liabilities of discontinued operations (1)

    -       24  

Cohu stockholders’ equity

    511,624       483,072  

Total liabilities & stockholders’ equity

  $ 1,095,511     $ 1,077,710  

 

(1)

On October 1, 2018, the Company made the decision to sell the fixtures business acquired from Xcerra, and, as a result, the fixtures business has been presented as discontinued operations since that date. The sale of this business was completed in February 2020.

 

 

COHU, INC.

Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited)

(in thousands, except per share amounts)

 

   

Three Months Ended

 
   

December 26,

   

September 26,

   

December 28,

 
   

2020

   

2020

   

2019

 

Income (loss) from operations - GAAP basis (a)

  $ 18,774     $ (1,360 )   $ (13,659 )

Non-GAAP adjustments:

                       

Share-based compensation included in (b):

                       

Cost of sales (COS)

    252       218       191  

Research and development (R&D)

    802       782       760  

Selling, general and administrative (SG&A)

    2,867       2,299       2,336  
      3,921       3,299       3,287  

Amortization of purchased intangible assets (c)

    9,898       9,783       9,615  

Restructuring charges related to inventory adjustments in COS (d)

    (550 )     2,606       2,408  

Restructuring charges (d)

    6,223       412       2,764  

Manufacturing and sales transition costs included in (e):

                       

COS

    26       -       -  

R&D

    6       -       -  

SG&A

    458       179       117  
      490       179       117  

Impairment charges (f)

    -       7,300       -  

Acquisition costs included in SG&A (g)

    -       -       28  

Gain on sale of facility (h)

    -       (4,468 )     -  

PP&E step-up included in SG&A (i)

    145       243       243  

Reduction of indemnification receivable included in SG&A (j)

    111       -       1,202  

Payroll taxes related to accelerated vesting of share-based awards included in SG&A (k)

    263       -       -  

Income from operations - non-GAAP basis (l)

  $ 39,275     $ 17,994     $ 6,005  
                         

Income (loss) from continuing operations - GAAP basis

  $ 14,861     $ (6,646 )   $ (16,281 )

Non-GAAP adjustments (as scheduled above)

    20,501       19,354       19,664  

Tax effect of non-GAAP adjustments (m)

    (3,556 )     (1,080 )     (3,914 )

Income (loss) from continuing operations - non-GAAP basis

  $ 31,806     $ 11,628     $ (531 )
                         

GAAP income (loss) from continuing operations per share - diluted

  $ 0.34     $ (0.16 )   $ (0.39 )
                         

Non-GAAP income (loss) from continuing operations per share - diluted (n)

  $ 0.73     $ 0.27     $ (0.01 )

Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Company's operating performance. Our management uses these non-GAAP financial measures in assessing the Company's operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Company’s financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Company’s operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization and impairment charges provides better comparability of pre and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Management initiated certain restructuring activities including employee headcount reductions and other organizational changes to align our business strategies in light of the merger with Xcerra. Restructuring costs have been excluded because such expense is not used by Management to assess the core profitability of Cohu’s business operations. Manufacturing and sales transition costs relate principally to expenses incurred as a result of moving certain manufacturing activities to Asia and incremental costs incurred related to the buildup of a direct sales force for certain equipment sales in Asia. Employee severance are costs incurred in conjunction with the termination of certain employees to streamline our operations and reduce costs. Management has excluded these costs primarily because they are not reflective of the ongoing operating results and they are not used to assess ongoing operational performance. Employer payroll taxes related to accelerated vesting share-based awards is dependent on the Company’s stock price, the number of awards vested and tax regulations specific to the country in which the employee resides, over which management has limited to no control and, as such, management does not believe it correlates to the Company’s operation of the business. Impairment charges and gain on sale of facility have been excluded as these amounts are infrequent and are unrelated to the operational performance of Cohu. Adjustments for inventory and PP&E step-up costs have been excluded by management as they are unrelated to the core operating activities of the Company and the frequency and variability in the nature of the charges can vary significantly from period to period. Excluding this data provides investors with a basis to compare Cohu’s performance against the performance of other companies without this variability. However, the non-GAAP financial measures should not be regarded as a replacement for (or superior to) corresponding, similarly captioned, GAAP measures. The presentation of non-GAAP financial measures above may not be comparable to similarly titled measures reported by other companies and investors should be careful when comparing our non-GAAP financial measures to those of other companies.

 

 

(a)

9.3%, (0.9)% and (9.6)% of net sales, respectively.

 

(b)

To eliminate compensation expense for employee stock options, stock units and our employee stock purchase plan.

 

(c)

To eliminate the amortization of acquired intangible assets.

 

(d)

To eliminate restructuring costs incurred related to the German operations and the integration of Xcerra.

 

(e)

To eliminate manufacturing and sales transition and severance costs.

 

(f)

To eliminate impairment charges recorded to adjust IPR&D assets obtained in the acquisition of Xcerra to current fair value.

 

(g)

To eliminate professional fees and other direct incremental expenses incurred related to the acquisition of Xcerra.

 

(h)

To eliminate the gains generated by the sale of the Company’s facilities in Rosenheim, Germany in the third quarter and Penang, Malaysia in the second quarter, sold as part of the previously announced Xcerra integration and restructuring program.

 

(i)

To eliminate the accelerated depreciation from the property, plant & equipment step-up related to the acquisition of Xcerra.

 

(j)

To eliminate the impact of the reduction of an uncertain tax position liability and related indemnification receivable.

 

(k)

To eliminate the impact of employer payroll taxes associated with the acceleration of Pascal Rondé share-based awards under the terms of his separation agreement.

 

(l)

19.4%, 11.9% and 4.2% of net sales, respectively.

 

(m)

To adjust the provision for income taxes related to the adjustments described above based on applicable tax rates.

 

(n)

All periods presented were computed using the number of GAAP diluted shares outstanding except the three months ended September 26, 2020 which was computed using 42,659 shares outstanding as the effect of dilutive securities was excluded from GAAP diluted common shares due to the reported net loss under GAAP, but are included for non-GAAP diluted common shares since the Company has non-GAAP net income.

 

COHU, INC.

Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited)

(in thousands, except per share amounts)

 

   

Twelve Months Ended

 
   

December 26,

   

December 28,

 
   

2020

   

2019

 

Income (loss) from operations - GAAP basis (a)

  $ 3,260     $ (52,328 )

Non-GAAP adjustments:

               

Share-based compensation included in (b):

               

Cost of sales (COS)

    893       736  

Research and development (R&D)

    3,245       2,994  

Selling, general and administrative (SG&A)

    10,096       10,418  
      14,234       14,148  

Amortization of purchased intangible assets (c)

    38,746       39,590  

Restructuring charges related to inventory adjustments in COS (d)

    3,731       2,729  

Restructuring charges (d)

    7,623       13,484  

Manufacturing and sales transition costs included in (e):

               

COS

    26       1,211  

R&D

    6       -  

SG&A

    776       1,383  
      808       2,594  

Impairment charges (f)

    11,249       -  
                 

Acquisition costs included in SG&A (g)

    -       432  

Gain on sale of facility (h)

    (4,495 )     -  

Inventory step-up included in COS (i)

    -       6,038  

PP&E step-up included in SG&A (j)

    874       4,014  

Reduction of indemnification receivable included in SG&A (k)

    111       1,202  

Payroll taxes related to accelerated vesting of share-based awards included in SG&A (l)

    263       -  
                 

Income from operations - non-GAAP basis (m)

  $ 76,404     $ 31,903  
                 

Loss from continuing operations - GAAP basis

  $ (13,843 )   $ (68,995 )

Non-GAAP adjustments (as scheduled above)

    73,144       84,231  

Tax effect of non-GAAP adjustments (n)

    (8,607 )     (11,456 )

Income from continuing operations - non-GAAP basis

  $ 50,694     $ 3,780  
                 

GAAP loss per share from continuing operations - diluted

  $ (0.33 )   $ (1.68 )
                 

Non-GAAP income per share - diluted (o)

  $ 1.19     $ 0.09  

 

Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Company's operating performance. Our management uses these non-GAAP financial measures in assessing the Company's operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Company’s financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Company’s operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Management initiated certain restructuring activities including employee headcount reductions and other organizational changes to align our business strategies in light of the merger with Xcerra. Restructuring costs have been excluded because such expense is not used by Management to assess the core profitability of Cohu’s business operations. Manufacturing and sales transition costs relate principally to expenses incurred as a result of moving certain manufacturing activities to Asia and incremental costs incurred related to the buildup of a direct sales force for certain equipment sales in Asia. Employee severance are costs incurred in conjunction with the termination of certain employees to streamline our operations and reduce costs. Management has excluded these costs primarily because they are not reflective of the ongoing operating results and they are not used to assess ongoing operational performance. Employer payroll taxes related to accelerated severance stock-based compensation are dependent on the company's stock price and the timing and size of the vesting of their restricted stock, over which management has limited to no control, and as such management does not believe it correlates to the company's operation of the business. Impairment charges and gain on sale of facility have been excluded as these amounts are infrequent and are unrelated to the operational performance of Cohu. Acquisition costs, fair value adjustment to contingent consideration and adjustments for inventory and PP&E step-up costs have been excluded by management as they are unrelated to the core operating activities of the Company and the frequency and variability in the nature of the charges can vary significantly from period to period. Excluding this data provides investors with a basis to compare Cohu’s performance against the performance of other companies without this variability. However, the non-GAAP financial measures should not be regarded as a replacement for (or superior to) corresponding, similarly captioned, GAAP measures. The presentation of non-GAAP financial measures above may not be comparable to similarly titled measures reported by other companies and investors should be careful when comparing our non-GAAP financial measures to those of other companies.

 

 

(a)

0.5% and (9.0)% of net sales, respectively.

 

(b)

To eliminate compensation expense for employee stock options, stock units and our employee stock purchase plan.

 

(c)

To eliminate the amortization of acquired intangible assets.

 

(d)

To eliminate restructuring costs incurred related to the German operations and the integration of Xcerra.

 

(e)

To eliminate manufacturing and sales transition and severance costs.

 

(f)

To eliminate impairment charges recorded to adjust IPR&D assets obtained in the acquisition of Xcerra to current fair value.

 

(g)

To eliminate professional fees and other direct incremental expenses incurred related to the acquisition of Xcerra.

 

(h)

To eliminate the gains generated by the sale of the Company’s facilities in Rosenheim, Germany and Penang, Malaysia sold as part of the previously announced Xcerra integration and restructuring program.

 

(i)

To eliminate the inventory step-up costs incurred related to the acquisition of Xcerra.

 

(j)

To eliminate the property, plant & equipment step-up depreciation accelerated related to the acquisition of Xcerra.

 

(k)

To eliminate the impact of the reduction of an uncertain tax position liability and related indemnification receivable.

 

(l)

To eliminate the impact of employer payroll taxes associated with the acceleration of Pascal Rondé share-based awards under the terms of his separation agreement.

 

(m)

12.0% and 5.5% of net sales, respectively.

 

(n)

To adjust the provision for income taxes related to the adjustments described above based on applicable tax rates.

 

(o)

The twelve months ended December 26, 2020 and December 26, 2019 were computed using 42,714 and 41,652 shares outstanding, respectively, as the effect of dilutive securities was excluded from GAAP diluted common shares due to the reported net loss under GAAP, but are included for non-GAAP diluted common shares since the Company has non-GAAP net income. All other periods were calculated utilizing the GAAP diluted shares outstanding.

 

COHU, INC.

                       

Supplemental Reconciliation of GAAP Results to Non-GAAP Financial Measures (Unaudited)

 

(in thousands)

                       
   

Three Months Ended

 
   

December 26,

   

September 26,

   

December 28,

 
   

2020

   

2020

   

2019

 
                         

Gross Profit Reconciliation

                       

Gross profit - GAAP basis (excluding amortization) (1)

  $ 91,241     $ 63,500     $ 54,075  

Non-GAAP adjustments to cost of sales (as scheduled above)

    (272 )     2,824       2,599  

Gross profit - Non-GAAP basis

  $ 90,969     $ 66,324     $ 56,674  
                         

As a percentage of net sales:

                       

GAAP gross profit

    45.1 %     42.2 %     38.1 %

Non-GAAP gross profit

    45.0 %     44.0 %     39.9 %
                         

Adjusted EBITDA Reconciliation

                       

Net income (loss) attributable to Cohu - GAAP Basis

  $ 14,861     $ (6,646 )   $ (17,266 )

Loss from discontinued operations

    -       -       1,039  

Income tax provision (benefit)

    405       1,116       (3,243 )

Interest expense

    2,855       3,021       4,767  

Interest income

    (14 )     (42 )     (161 )

Amortization of purchased intangible assets

    9,898       9,783       9,615  

Depreciation

    3,565       3,462       3,893  

Amortization of cloud-based software implementation costs (2)

    360       318       -  

Other non-GAAP adjustments (as scheduled above)

    10,458       9,328       9,806  

Adjusted EBITDA

  $ 42,388     $ 20,340     $ 8,450  
                         

As a percentage of net sales:

                       

Net income (loss) attributable to Cohu - GAAP Basis

    7.3 %     (4.4 )%     (12.2 )%

Adjusted EBITDA

    20.9 %     13.5 %     6.0 %
                         

Operating Expense Reconciliation

                       

Operating Expense - GAAP basis

  $ 72,467     $ 64,860     $ 67,734  

Non-GAAP adjustments to operating expenses (as scheduled above)

    (20,773 )     (16,530 )     (17,065 )

Operating Expenses - Non-GAAP basis

  $ 51,694     $ 48,330     $ 50,669  

(1)

Excludes amortization of $7,541, $7,447 and $7,263 for the three months ending December 26, 2020, September 26, 2020 and December 28, 2019, respectively.

(2)

Represents amortization of capitalized implementation costs related to cloud-based software arrangements that are included within SG&A.

 

   

Twelve Months Ended

 
   

December 26,

   

December 28,

 
   

2020

   

2019

 

Gross Profit Reconciliation

               

Gross profit - GAAP basis (excluding amortization) (1)

  $ 271,782     $ 229,829  

Non-GAAP adjustments to cost of sales (as scheduled above)

    4,650       10,714  

Gross profit - Non-GAAP basis

  $ 276,432     $ 240,543  
                 

As a percentage of net sales:

               

GAAP gross profit

    42.7 %     39.4 %

Non-GAAP gross profit

    43.5 %     41.2 %
                 

Adjusted EBITDA Reconciliation

               

Net loss attributable to Cohu - GAAP Basis

  $ (13,801 )   $ (69,700 )

(Income) loss from discontinued operations

    (42 )     697  

Income tax provision (benefit)

    666       (3,082 )

Interest expense

    13,759       20,556  

Interest income

    (224 )     (764 )

Amortization of purchased intangible assets

    38,746       39,590  

Depreciation

    14,000       19,246  

Amortization of cloud-based software implementation costs (2)

    1,191       -  

Other non-GAAP adjustments (as scheduled above)

    33,524       39,534  

Adjusted EBITDA

  $ 87,819     $ 46,077  
                 

As a percentage of net sales:

               

Net income (loss) attributable to Cohu - GAAP Basis

    (2.2 )%     (11.9 )%

Adjusted EBITDA

    13.8 %     7.9 %
                 

Operating Expense Reconciliation

               

Operating Expense - GAAP basis

  $ 268,522     $ 282,157  

Non-GAAP adjustments to operating expenses (as scheduled above)

    (68,494 )     (73,517 )

Operating Expenses - Non-GAAP basis

  $ 200,028     $ 208,640  

(1)

Excludes amortization of $29,510 and $30,126 for the twelve months ending December 26, 2020 and December 28, 2019, respectively.

(2)

Represents amortization of capitalized implementation costs related to cloud-based software arrangements that are included within SG&A.